These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli. Madsen LM, Inada M, Weiss J. Infect Immun; 1996 Jul; 64(7):2425-30. PubMed ID: 8698462 [Abstract] [Full Text] [Related]
9. Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. Elsbach P, Weiss J, Franson RC, Beckerdite-Quagliata S, Schneider A, Harris L. J Biol Chem; 1979 Nov 10; 254(21):11000-9. PubMed ID: 500619 [Abstract] [Full Text] [Related]
10. Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils. Weiss J, Victor M, Cross AS, Elsbach P. Infect Immun; 1982 Dec 10; 38(3):1149-53. PubMed ID: 6759406 [Abstract] [Full Text] [Related]
11. The role of phospholipase A2 lysines in phospholipolysis of Escherichia coli killed by a membrane-active neutrophil protein. Forst S, Weiss J, Elsbach P. J Biol Chem; 1982 Dec 10; 257(23):14055-7. PubMed ID: 6815187 [Abstract] [Full Text] [Related]
12. Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. Weiss J, Victor M, Elsbach P. J Clin Invest; 1983 Mar 10; 71(3):540-9. PubMed ID: 6338040 [Abstract] [Full Text] [Related]
13. The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins. Qi SY, Li Y, O'Connor CD. Biochem J; 1994 Mar 15; 298 Pt 3(Pt 3):711-8. PubMed ID: 8141787 [Abstract] [Full Text] [Related]
14. Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate. Forst S, Weiss J, Elsbach P, Maraganore JM, Reardon I, Heinrikson RL. Biochemistry; 1986 Dec 30; 25(26):8381-5. PubMed ID: 3548813 [Abstract] [Full Text] [Related]
16. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. Weinrauch Y, Abad C, Liang NS, Lowry SF, Weiss J. J Clin Invest; 1998 Aug 01; 102(3):633-8. PubMed ID: 9691100 [Abstract] [Full Text] [Related]
17. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. Mannion BA, Weiss J, Elsbach P. J Clin Invest; 1990 Mar 01; 85(3):853-60. PubMed ID: 2179269 [Abstract] [Full Text] [Related]
18. Synergy between extracellular group IIA phospholipase A2 and phagocyte NADPH oxidase in digestion of phospholipids of Staphylococcus aureus ingested by human neutrophils. Femling JK, Nauseef WM, Weiss JP. J Immunol; 2005 Oct 01; 175(7):4653-61. PubMed ID: 16177112 [Abstract] [Full Text] [Related]
19. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. Mannion BA, Weiss J, Elsbach P. J Clin Invest; 1990 Aug 01; 86(2):631-41. PubMed ID: 2200807 [Abstract] [Full Text] [Related]
20. Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. Wright GW, Ooi CE, Weiss J, Elsbach P. J Biol Chem; 1990 Apr 25; 265(12):6675-81. PubMed ID: 2182625 [Abstract] [Full Text] [Related] Page: [Next] [New Search]